01 1Aurobindo Pharma Limited
02 1Cipla Ltd.
03 1Hetero Drugs Limited
04 1SK BIOTEK IRELAND LIMITED
05 1ScinoPharm Taiwan Ltd.
06 1Siegfried Evionnaz SA
07 1Wisdom Pharmaceutical Co.,Ltd
08 1Yung Shin Pharmaceutical Ind. Co., Ltd.
09 1Zhejiang Ausun Pharmaceutical Co., Ltd.
10 1Zhejiang Huahai Pharmaceutical Co., Ltd.
01 1ENTECAVIR
02 6Entecavir
03 1Entecavir Monohydrate
04 1Entecavir monohydrate
05 1entecavir monohydrate
01 4China
02 3India
03 1Switzerland
04 1Taiwan
05 1U.S.A
NDC Package Code : 65862-798
Start Marketing Date : 2023-12-06
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7692
Start Marketing Date : 2010-01-05
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0086
Start Marketing Date : 2005-03-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-1255
Start Marketing Date : 2011-06-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17381-031
Start Marketing Date : 2012-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50193-1611
Start Marketing Date : 2007-02-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 13612-0020
Start Marketing Date : 2020-09-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63126-903
Start Marketing Date : 2014-02-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76397-001
Start Marketing Date : 2015-02-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 64220-160
Start Marketing Date : 2024-09-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Entecavir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Entecavir, including repackagers and relabelers. The FDA regulates Entecavir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Entecavir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Entecavir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Entecavir supplier is an individual or a company that provides Entecavir active pharmaceutical ingredient (API) or Entecavir finished formulations upon request. The Entecavir suppliers may include Entecavir API manufacturers, exporters, distributors and traders.
click here to find a list of Entecavir suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Entecavir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Entecavir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Entecavir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Entecavir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Entecavir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Entecavir suppliers with NDC on PharmaCompass.
We have 10 companies offering Entecavir
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
